Peng Qi1, Xi-Quan Zhang2, Xin-Yan Pang1, Guang-Qing Cao2, Chang-Cun Fang2, Shu-Ming Wu2. 1. Department of Cardiac Surgery, Intensive Care Unit, Qilu Hospital of Shandong University Jinan, Shandong Province, China. 2. Department of Cardiac Surgery, Qilu Hospital of Shandong University Jinan, Shandong Province, China.
Abstract
OBJECTIVE: To investigate the effect of continuous venovenous hemofiltration (CVVH) for aortic dissection patients with acute renal failure after surgery in retrospective manner. METHODS: A total of thirty-seven aortic dissection patients with postoperative acute renal failure accepted CVVH therapy. The effect of CVVH was evaluated by analyzing clinical condition changes and laboratory examination results. RESULTS: After treatment of CVVH, renal function and clinical symptoms were significantly improved in thirty patients. Eight of the thirty patients got completely renal function recovery within two weeks after CVVH therapy; and twenty-two of the thirty patients got completely renal function recovery within four weeks after CVVH therapy. Nevertheless, seven patients got no benefit from CVVH therapy with poor prognosis. CONCLUSION: CVVH is an effective treatment to most aortic dissection patients with postoperative acute renal failure. The effect of CVVH was correlated with original renal function, early CVVH therapy, and continuous intensive care.
OBJECTIVE: To investigate the effect of continuous venovenous hemofiltration (CVVH) for aortic dissection patients with acute renal failure after surgery in retrospective manner. METHODS: A total of thirty-seven aortic dissection patients with postoperative acute renal failure accepted CVVH therapy. The effect of CVVH was evaluated by analyzing clinical condition changes and laboratory examination results. RESULTS: After treatment of CVVH, renal function and clinical symptoms were significantly improved in thirty patients. Eight of the thirty patients got completely renal function recovery within two weeks after CVVH therapy; and twenty-two of the thirty patients got completely renal function recovery within four weeks after CVVH therapy. Nevertheless, seven patients got no benefit from CVVH therapy with poor prognosis. CONCLUSION:CVVH is an effective treatment to most aortic dissection patients with postoperative acute renal failure. The effect of CVVH was correlated with original renal function, early CVVH therapy, and continuous intensive care.
Authors: N Morelli; E Rota; M Mancuso; P Immovilli; M Spallazzi; G Rocca; E Michieletti; D Guidetti Journal: Int J Stroke Date: 2013-12 Impact factor: 5.266
Authors: Amit Jain; Margaret C Tracci; Dawn M Coleman; Kenneth J Cherry; Gilbert R Upchurch Journal: Semin Vasc Surg Date: 2014-06-12 Impact factor: 1.000
Authors: Michalis N Gionis; George Kaimasidis; Emmanouel Tavlas; Nikolaos Kontopodis; Marina Plataki; Alexandros Kafetzakis; Christos V Ioannou Journal: Am J Case Rep Date: 2013-02-22